Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myelomaFaith E. Davies, Kenneth C. Anderson, Teru Hideshima et al.|Blood|2001Cited by 905
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implicationsKlaus Podar, Kenneth C. Anderson|Blood|2004Cited by 341
Essential Role of Caveolae in Interleukin-6- and Insulin-like Growth Factor I-triggered Akt-1-mediated Survival of Multiple Myeloma CellsKlaus Podar, Kenneth C. Anderson|Journal of Biological Chemistry|2003Cited by 144
The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implicationsKlaus Podar, Kenneth C. Anderson|British Journal of Haematology|2011Cited by 77
Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signalingMarc S. Raab, Klaus Podar|Blood|2008Cited by 64